85866-0223 TREGZI - CanMED: NDC

Product NDC:

85866-0223

Brand Name:

TREGZI

Generic Name:

Allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq

Dosage Form Name:

KIT

Administration Route:

Intravenous

Substances:

Name: LEUKOCYTE ANTIGEN MATCHED ALLOGENEIC HUMAN REGULATORY T CELLS

Strength: 3500000.0

Unit: /100ml

Name: CD34 ENRICHED ALLOGENEIC HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS

Strength: 1000000.0

Unit: /100ml

Name: LEUKOCYTE ANTIGEN MATCHED ALLOGENEIC HUMAN T CELLS

Strength: 6900000.0

Unit: /15ml

Packages:

Code: 85866-0223-04

Description: 1 KIT in 1 CARTON (85866-223-04) * 100 mL in 1 BAG (85866-124-01) * 1 BAG in 1 CARTRIDGE (85866-126-02) / 15 mL in 1 BAG (85866-126-01) * 1 BAG in 1 CARTON (85866-127-02) / 30 mL in 1 BAG (85866-127-01) * 100 mL in 1 BAG (85866-125-01)

Effective Date: June 30, 2026

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Allogeneic Regulatory T cells

Minor Class:

Treg, Tcon, HSPC

Orphan Drug Designation:

Yes

Status:

In Use

CanMED and the Oncology Toolbox

CanMED: NDC